These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29189693)

  • 1. Practice Bulletin No. 187: Neural Tube Defects.
    Obstet Gynecol; 2017 Dec; 130(6):e279-e290. PubMed ID: 29189693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice Bulletin No. 187 Summary: Neural Tube Defects.
    Obstet Gynecol; 2017 Dec; 130(6):1394-1396. PubMed ID: 29189691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACOG practice bulletin. Neural tube defects. Number 44, July 2003. (Replaces committee opinion number 252, March 2001).
    Cheschier N;
    Int J Gynaecol Obstet; 2003 Oct; 83(1):123-33. PubMed ID: 14626221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spina bifida and other neural tube defects.
    Northrup H; Volcik KA
    Curr Probl Pediatr; 2000; 30(10):313-32. PubMed ID: 11147289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural tube defects in the sample of genetic counselling.
    Joó JG; Beke A; Papp C; Tóth-Pál E; Csaba A; Szigeti Z; Papp Z
    Prenat Diagn; 2007 Oct; 27(10):912-21. PubMed ID: 17602445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of neural tube defects in Asturias (Spain): impact of prenatal diagnosis].
    García López E; Rodríguez Dehli C; Ariza Hevia F; Rodríguez Fernández A; Fernández Toral J; Riaño Galán I; Mosquera Tenreiro C
    Gac Sanit; 2009; 23(6):506-11. PubMed ID: 19406531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Aug; 59(31):980-4. PubMed ID: 20703205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in prevalence of neural tube defects in a high-risk region of the United States.
    Stevenson RE; Allen WP; Pai GS; Best R; Seaver LH; Dean J; Thompson S
    Pediatrics; 2000 Oct; 106(4):677-83. PubMed ID: 11015508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PATTERNS OF NEURAL TUBE DEFECTS AT TWO TEACHING HOSPITALS IN ADDIS ABABA, ETHIOPIA A THREE YEARS RETROSPECTIVE STUDY.
    Sorri G; Mesfin E
    Ethiop Med J; 2015 Jul; 53(3):119-26. PubMed ID: 26677521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.
    Wilson RD; ; Wilson RD; Audibert F; Brock JA; Carroll J; Cartier L; Gagnon A; Johnson JA; Langlois S; Murphy-Kaulbeck L; Okun N; Pastuck M; ; Deb-Rinker P; Dodds L; Leon JA; Lowel HL; Luo W; MacFarlane A; McMillan R; Moore A; Mundle W; O'Connor D; Ray J; Van den Hof M
    J Obstet Gynaecol Can; 2015 Jun; 37(6):534-52. PubMed ID: 26334606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of folic acid supplementation during different pregnancy periods and relationship with the other primary prevention measures to neural tube defects.
    Gong R; Wang ZP; Wang M; Gao LJ; Zhao ZT
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3894-901. PubMed ID: 27023398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects.
    MMWR Recomm Rep; 1992 Sep; 41(RR-14):1-7. PubMed ID: 1522835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of spina bifida at birth--United States, 1983-1990: a comparison of two surveillance systems.
    Lary JM; Edmonds LD
    MMWR CDC Surveill Summ; 1996 Apr; 45(2):15-26. PubMed ID: 8602137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural tube defects: epidemiology, detection, and prevention.
    Cohen FL
    J Obstet Gynecol Neonatal Nurs; 1987; 16(2):105-15. PubMed ID: 2437270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
    Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
    Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
    Chen CP
    Taiwan J Obstet Gynecol; 2008 Sep; 47(3):283-90. PubMed ID: 18935990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETIRED: Prenatal screening, diagnosis, and pregnancy management of fetal neural tube defects.
    Wilson RD; ;
    J Obstet Gynaecol Can; 2014 Oct; 36(10):927-939. PubMed ID: 25375307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness of risk factors and preventive measures for neural tube defects: Perception towards pregnancy termination in the Saudi population.
    Babgi MA; Al-Jifree HM; AlShehri OA; Khan MA; Khogeer AN; Alqurashi MA
    J Neonatal Perinatal Med; 2019; 12(2):195-201. PubMed ID: 30932895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outcome and course of pregnancies complicated with fetal neural tube defects.
    Steric M; Stamenkovic JD; Srbinovic L; Janjic T; Petronijevic SV; Petronijevic M; Cetkovic A
    Clin Exp Obstet Gynecol; 2015; 42(1):57-61. PubMed ID: 25864283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for neural tube defects.
    Drugan A; Weissman A; Evans MI
    Clin Perinatol; 2001 Jun; 28(2):279-87, vii. PubMed ID: 11499052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.